🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Happy Easter from everyone at mowoot! 🐰🐣🌷

📢New #investment opportunity in #MOWOOT! We are raising a bridge-funding round with Capital Cell to support our international expansion & growth. ⌛Dont miss the 5% early-bird dicount! More info here: capitalcell.es/campaign/mowoo…

NEWS | mowoot leads a project on developing an innovative therapy with Next Generation EU funding, in collaboration with Eurecat Events 👉 tuit.cat/QuOUw

💜 Today is #WorldIBSDay2024 & we announce that #MOWOOT has been granted a € 2,2 million publicly funded project to develop a novel #digital solution for Irritable Bowel Syndrome #IBS, in collaboration with Eurecat & IDIAPJGol! More info here👇 mowoot.com/en/mowoot-lead…

📰 ES: "𝐏𝐚𝐫𝐚 𝐮𝐧 𝐢𝐧𝐭𝐞𝐬𝐭𝐢𝐧𝐨 𝐦𝐞𝐧𝐨𝐬 𝐢𝐫𝐫𝐢𝐭𝐚𝐛𝐥𝐞" - Ayer en La Vanguardia: nuestro proyecto del síndrome del intestino irritable #SII & nuestra ronda de inversión en Capital Cell! 📰 EN: "𝐅𝐨𝐫 𝐚 𝐥𝐞𝐬𝐬 𝐢𝐫𝐫𝐢𝐭𝐚𝐛𝐥𝐞 𝐛𝐨𝐰𝐞𝐥" #IBS in the news

Spanish #innovation portal El Referente publishes an article (in spanish) about #MOWOOT. 👉elreferente.es/actualidad/los… #boweldysfunction #ibs #sii

📰ES: iSanidad dedica un articulo a nuestro proyecto de dar una solución al Síndrome del Intestino Irritable #SII. 📰EN_ iSanidad dedicates an article to our project to develop a solution for Irritable Bowel Syndrome #IBS. isanidad.com/281282/mas-de-…

Go IHF! Go mowoot! 🚀

🌟 Exciting news! mowoot secures €2M+ from Next Generation funds to develop a digital platform for managing Irritable Bowel Syndrome (IBS), supported by EIT Health. Learn more about MOWOOT's innovative IBS management: loom.ly/Gi4NUqk #HealthTech #IBSManagement

📣​ #LoMásLeído| 🗞️​ #Actualidad| La start-up mowoot lidera la investigación para el desarrollo de una plataforma digital para la monitorización y el tratamiento del síndrome del intestino irritable (SII) #Sanidad #Médicos #ActualidadSanitaria i.mtr.cool/lqutejyevs

📢 Calling all #BioRegion early-stage startups looking for #funding & licensing deals: Apply to the Innovator's Pitch Challenge at #RESIEurope2024 and #pitch to leading #investors Apply here ➡tuit.cat/6Zsms Why should you seize this opportunity ⁉ Here's the reason 👇

MOWOOT recibe 2 millones de euros de fondos Next Generation para desarrollar una plataforma digital contra el Síndrome del Intestino Irritable. EIT Health ha sido clave en su éxito. Descubre cómo: eithealth.eu/news-article/m…… mowoot Markus Wilhelms

🔜 Next Tuesday, May 7th, we will participate in @CataloniaBioHT #ConnectionDay24. 🔎You can see our pitch at the #Health #Investment Forum organized by ACCIÓ and/or schedule a meeting w/ our CEO Markus Wilhelms. Register and book your meetings here: 👉 lnkd.in/dNHe7YmG

See you next Tuesday at #ConnectionDay24 organized by @CataloniaBioHT & ACCIÓ!

#ClienteEnisa mowoot Más de 2 M€ de fondos europeos para conseguir la primera terapia eficaz que trate el síndrome del intestino irritable vía iSanidad  isanidad.com/281282/mas-de-…

¿Indeciso sobre una inversión en #MOWOOT a través de Capital Cell? Ven a ver nuestro CEO Markus Wilhelms presentar #MOWOOT en el #ConnectionDay24 de @CataloniaBioHT & ACCIÓ. 📌 Mañana, martes 07.05.2025, a las 11h en el #Health #Investment Forum 👉cataloniabioht.org/events/connect…

📢 ¡No te pierdas la oportunidad online de conocer a #MOWOOT y los detalles de nuestra ronda actual de #crowdfunding con Capital Cell! 𝐇𝐨𝐲 𝐣𝐮𝐞𝐯𝐞𝐬, 9 𝐝𝐞 𝐦𝐚𝐲𝐨 𝐚 𝐥𝐚𝐬 18𝐡. 👉 Es necesaria la inscripción previa: lnkd.in/drimzRSh

Today is #WorldMSDay! ➡ Multiple sclerosis (#MS) has many different symptoms, including bowel dysfunction. ➡ The majority (85%) of patients find most of these symptoms embarrassing. It´s time to talk openly about bowel dysfunction & give them the support they need!

Please support us & mowoot with your vote!

📢This week MOWOOT CoFounder & CSO Dr. IHF presents the effectiveness of 'Intermittent Colonic Exoperistalsis' & the #MOWOOT device in patients with #constipation induced by medicine (MiC) at the United European Gastroenterology congress in Vienna. #UEGWeek my_UEG